Norlase
PrivateLast Round
Debt
Feb 27, 2025
Est. Valuation
$60M
Total Funding Raised
$14.07M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Norlase is a medical device company that develops and manufactures next-generation laser solutions for the treatment of retina and glaucoma diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Norlase Comparables
Compare Norlase with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OD-OS GmbH | 81% | |
| Lumibird | 80% | |
| IRIDEX Corporation | 78% |
Norlase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 27, 2025 | ||||
| VC Round | May 23, 2023 | ||||
| Series B | Oct 25, 2021 | ||||
| Series A | Mar 1, 2019 | ||||
| Grant | Dec 17, 2014 |
Key People
Founding team and executive leadership
Norlase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Investment Bank Group | Debt |
| West Hill Capital | Series A, Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 34% MoM, reaching 10.7K.
- May 16, 2026
Monthly visitors increased 88% MoM, reaching 16.4K.
Recent news
Latest coverage and updates
- hiresSep 8, 2026
Norlase hired Heather Robbins as National Sales Director, UK on Sep 8th '26.
- attends_eventSep 8, 2026
Norlase attends event ESCRS 2026.
- attends_eventSep 8, 2026
Norlase will attend event 44th Congress on Sep 11th '26.
- launchesSep 8, 2026
Norlase will launch Lynx Pattern LIO and Echo Pattern Laser at 44th Congress on Sep 11th '26.
- receives_awardJul 1, 2026
Norlase received award Prism Award at Prism Awards on Jul 1st '25.
Norlase Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Norlase's valuation, stock price, and market status.
Is Norlase a public or private company?
Norlase is a private company.
What is the current stock price of Norlase?
Norlase is a private company with no public stock price. No recent secondary market data is available.
How much is Norlase worth (valuation)?
Norlase's valuation is estimated at $60.0M based on funding round data.
Can I buy Norlase stock?
Norlase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Norlase's last funding round?
Norlase's most recent funding round was Debt on October 25, 2021.
Who are the main investors in Norlase?
Key investors in Norlase include West Hill Capital.
Will Norlase IPO soon?
No public IPO plans have been announced for Norlase.
How can I track Norlase secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Norlase's secondary market activity and sign up for updates.